<- Go Home
Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States.
Market Cap
$54.1M
Volume
69.6K
Cash and Equivalents
$34.9M
EBITDA
-$94.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$72.4M
Profit Margin
N/A
52 Week High
$11.35
52 Week Low
$5.20
Dividend
N/A
Price / Book Value
0.40
Price / Earnings
-0.56
Price / Tangible Book Value
0.40
Enterprise Value
-$77.4M
Enterprise Value / EBITDA
0.86
Operating Income
-$96.0M
Return on Equity
-54.72%
Return on Assets
-29.02
Cash and Short Term Investments
$148.4M
Debt
$16.9M
Equity
$134.0M
Revenue
N/A
Unlevered FCF
-$42.3M
Sector
Biotechnology
Category
N/A